Increased level of tumor necrosis factor-α in patients with antiphospholipid syndrome: Marker not only of inflammation but also of the prothrombotic state

Rheumatology International

Volumn 31, Issue 3, 2011, Pages 307-313

  Swadzba, Jakub ^a   Iwaniec, Teresa ^a   Musial, Jacek ^a  

^a JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

Author keywords

Antiphospholipid syndrome; Inflammation; sIL 2R; Thrombosis; TNF

Indexed keywords

BETA2 GLYCOPROTEIN 1; CARDIOLIPIN ANTIBODY; COMPLEMENT COMPONENT C4; DOUBLE STRANDED DNA; IMMUNOGLOBULIN G ANTIBODY; LA ANTIBODY; LUPUS ANTICOAGULANT; PHOSPHOLIPID ANTIBODY; RIBONUCLEOPROTEIN ANTIBODY; RO ANTIBODY; SM ANTIBODY; SOLUBLE INTERLEUKIN 2 RECEPTOR; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ANTIBODY BLOOD LEVEL; ANTIPHOSPHOLIPID SYNDROME; ARTERY THROMBOSIS; ARTHRITIS; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE MARKER; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FETUS WASTAGE; HEMATOLOGIC DISEASE; HUMAN; IMMUNOPATHOGENESIS; INFLAMMATION; KIDNEY DISEASE; LUPUS LIKE SYNDROME; MAJOR CLINICAL STUDY; MALE; NEUROLOGIC DISEASE; PARTIAL THROMBOPLASTIN TIME; PREGNANCY COMPLICATION; PRIORITY JOURNAL; SKIN LUPUS ERYTHEMATOSUS; SYSTEMIC LUPUS ERYTHEMATOSUS; VEIN THROMBOSIS;

ADOLESCENT; ADULT; AGED; ANTIBODIES, ANTIPHOSPHOLIPID; ANTIPHOSPHOLIPID SYNDROME; BIOLOGICAL MARKERS; FEMALE; HUMANS; INFLAMMATION; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; RECEPTORS, INTERLEUKIN-2; STATISTICS, NONPARAMETRIC; TUMOR NECROSIS FACTOR-ALPHA;

EID: 79954444111     PISSN: 01728172     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00296-009-1314-8     Document Type: Article

References (44)

1. M Hoffman DM Monroe RAS Roubey 2001 Links between the immune and coagulation systems: how do "antiphospholipid antibodies" cause thrombosis? Immunol Res 22 109 116
2. CT Esmon 2003 Inflammation and thrombosis J Thromb Haemost 1 1343 1348 1:CAS:528:DC%2BD2cXktFOjs70%3D 10.1046/j.1538-7836.2003.00261.x 12871267
3. MP Bevilaqua JS Pober GR Majeau W Fiers RS Cotran MA Gimbrone 1986 Recombinant tumor necrosis factor induces procoagulant activity in cultured human vascular endothelium: characterization and comparison with the actions of interleukin 1 Proc Natl Acad Sci USA 83 4533 4537 10.1073/pnas.83.12.4533 (Pubitemid 16057083)
4. PJ Sims PM Faioni T Wiedmer SJ Shattil 1988 Complement proteins C5b-9 cause release of membrane vesicles from the platelet surface that are enriched in the membrane receptor for coagulation factor Va and express prothrombinase activity J Biol Chem 263 18205 18212 1:CAS:528:DyaL1cXlvVynt74%3D 2848029 (Pubitemid 19005097)
5. J Wu MJ Stevenson JM Brown EA Grunz TL Strawn WP Fay 2008 C-reactive protein enchances tissue factor expression by vascular smooth muscle cells Arterioscler Thromb Vasc Biol 28 698 704 1:CAS:528:DC%2BD1cXjt1Slt7c%3D 10.1161/ATVBAHA.107.160903 18276908 (Pubitemid 351651347)
6. EM Conway RD Rosenberg 1988 Tumor necrosis factor suppresses transcription of the trombomodulin gene in endothelial cells Mol Cell Biol 8 5588 5592 1:CAS:528:DyaL1MXjslGmsA%3D%3D 2854203
7. AJ Chu 2005 Tissue factor mediates inflammation Arch Biochem Biophys 400 123 132 10.1016/j.abb.2005.06.005 (Pubitemid 41140376)
8. DL Miller R Yaron MJ Yellin 1998 CD40L-CD40 interaction regulate endothelial cell surface tissue factor and thrombomodulin expression J Leukoc Biol 63 373 379 1:CAS:528:DyaK1cXhs1OqtLY%3D 9500526 (Pubitemid 28106852)
9. SS Pierangeli RG Espinola X Liu EN Harris 2001 Thrombogenic effects of antiphospholipid antibodies are mediated by intracellular adhesion molecule-1, vascular cell adhesion molecule-1 and P-selectin Circ Res 88 245 250 1:CAS:528:DC%2BD3MXhtVaisrc%3D 11157679 (Pubitemid 32147315)
10. JTB Crawley M Efthymiou 2008 Cytoprotective effect of activated protein C: specificity of PAR-1 signaling J Thromb Haemost 6 951 953 1:CAS:528:DC%2BD1cXotFaqtb4%3D 10.1111/j.1538-7836.2008.02951.x 18363817 (Pubitemid 351689916)
11. A Studnicka-Benke G Steiner P Petera JS Smolen 1996 Tumour necrosis factor alpha and its soluble receptors parallel clinical disease and autoimmune activity in systemic lupus erythematosus Br J Rheumatol 35 1067 1074 1:STN:280:DyaK2s7gsVWhtw%3D%3D 10.1093/rheumatology/35.11.1067 8948291
12. RR Forastiero ME Martinuzzo GF de Larranaga 2005 Circulating levels of tissue factor and proinflamatory cytokines in patients with primary antiphospholipid syndrome or leprosy related antiphospholipid antibodies Lupus 14 129 136 1:CAS:528:DC%2BD2MXis1Smtb8%3D 10.1191/0961203305lu2048oa 15751817 (Pubitemid 40327663)
13. LA Rubin 1990 The soluble interleukin-2 receptor: biology function and clinical application Ann Intern Med 113 619 627 1:CAS:528:DyaK3MXkt1Ohsr0%3D 2205142 (Pubitemid 20346191)
14. RE Wolf WG Brelsford 1988 Soluble interleukin-2 receptors in systemic lupus erythematosus Arthritis Rheum 31 729 735 1:STN:280:DyaL1c3ltFGjsQ%3D%3D 10.1002/art.1780310605 3132927
15. C Neish M Charley N Fertig T Medsger JS Deng 1993 Elevated serum soluble interleukin-2 receptor levels in subacute cutaneus lupus erythematosus J Dermatol Sci 5 143 149 1:STN:280:DyaK2c%2FlvFyrtQ%3D%3D 10.1016/0923-1811(93) 90761-D 7694647 (Pubitemid 23265472)
16. S Miyakis MD Lockshin T Atsumi DW Branch RL Brey R Cervera RHWM Derksen PG de Groot T Koike PL Meroni G Reber Y Shoenfeld A Tincani PG Vlachoyiannopoulos SA Krilis 2006 International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS) J Thromb Haemost 4 295 306 1:CAS:528:DC%2BD28XisVSjuro%3D 10.1111/j.1538-7836. 2006.01753.x 16420554
17. MC Hochberg 1997 Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus Arthritis Rheum 40 1725 1:STN:280:DyaK2svmsVaisw%3D%3D 10.1002/art.1780400928 9324032
18. JT Brandt DA Triplett B Alving I Scharer 1995 Criteria for the diagnosis of lupus anticoagulants: an update Thromb Haemost 74 1185 1190 1:CAS:528:DyaK2MXptVyhs7Y%3D 8560433
19. J Swadźba LS de Clerck WJ Stevens CH Bridts KA van Cotthem J Musial M Jankowski A Szczeklik 1997 Anticardiolipin antibodies, anti-β2-glycoprotein I, antiprothrombin antibodies and lupus anticoagulant in patients with systemic lupus erythematosus with a history of thrombosis J Rheumatol 24 1710 1715 9292792 (Pubitemid 27394506)
20. K Ichikawa A Tsutsumi T Atsumi E Matsuura S Kobayashi GR Hughes MA Khamashta T Koike 1999 A chimeric antibody with the human gamma1 constant region as putative standard for assays to detect IgG beta2-glycoprotein I-dependent anticardiolipin and anti-beta2-glycoprotein I antibodies Arthritis Rheum 42 2461 2470 1:CAS:528:DyaK1MXnvVShsbs%3D 10.1002/1529-0131(199911)42:11<2461::AID- ANR25>3.0.CO;2-O 10555042 (Pubitemid 30333427)
21. RCW Wong 2004 Consensus guidelines for anticardiolipin antibody testing Thromb Res 114 559 571 1:CAS:528:DC%2BD2cXovVKmsLc%3D 10.1016/j.thromres.2004. 06.002 15507292 (Pubitemid 39422592)
22. J Swadźba M Sanak T Iwaniec S Dziedzina J Musiał 2006 Valine/leucine 247 polymorphism of β2GPI in patients with antiphospholipid syndrome: lack of association with anti-β2GPI antibodies Lupus 15 218 222 10.1191/0961203306lu2288oa 16686261
23. EM Davas A Tsirogianni I Kappou D Karamitsos I Economidou PC Dantis 1999 Serum IL-6, TNFα, p55 srTNFα, p75 srTNFα, srIL-2α levels and disease activity in systemic lupus erythematosus Clin Rheumatol 18 17 22 1:STN:280:DyaK1M7os1yjtg%3D%3D 10.1007/s100670050045 10088943 (Pubitemid 29104747)
24. K Oku T Atsumi M Bohgaki O Amengual H Kataoka T Horita S Yasuda T Koike 2009 Complement activation in patients with primary antiphospholipid syndrome Ann Rheum Dis 68 1030 1035 1:CAS:528:DC%2BD1MXotVCjurs%3D 10.1136/ard.2008. 090670 18625630
25. ML Bertolaccini T Atsumi JS Lanchbury AR Caliz K Katsumata RW Vaughan E Kondeatis MA Khamashta T Koike GRV Hughes 2001 Plasma tumor necrosis factor α levels and the-238*A promoter polymorphism in patients with antiphospholipid syndrome Thromb Haemost 85 198 203 1:CAS:528: DC%2BD3MXhvVKku7c%3D 11246532 (Pubitemid 32140560)
26. B Cambien W Bergmeier S Saffaripour Mitchell DD Wagner 2003 Antithrombotic activity of TNF-α J Clin Invest 112 1589 1596 1:CAS:528:DC%2BD3sXptFWqtLk%3D 14617760
27. J Swadzba T Iwaniec A Szczeklik J Musial 2007 Revised classification criteria for antiphospholipid syndrome and the thrombotic risk in patients with autoimmune diseases J Thromb Haemost 5 1883 1889 1:STN:280: DC%2BD2srgt1Gkuw%3D%3D 10.1111/j.1538-7836.2007.02669.x 17596131 (Pubitemid 47288946)
28. M Galli G Reber P de Moerloose PG de Groot 2008 Invitation to a debate on the serological criteria that define the antiphospholipid syndrome J Thromb Haemost 6 399 401 1:STN:280:DC%2BD1c%2FmtFWjuw%3D%3D 18067604
29. J Swadzba J Musiał 2009 More on: the debate on antiphospholipid syndrome classification criteria J Thromb Haemost 7 501 502 1:STN:280: DC%2BD1M7jtlKktQ%3D%3D 10.1111/j.1538-7836.2009.03274.x 19143929
30. J Berman G Girardi JE Salmon 2005 TNF-alpha is a critical effector and a target for therapy in antiphospholipid antibody-induced pregnancy loss J Immunol 174 45 90
31. D Tanne A Katzav O Beilin NC Grigoriadis M Blank GG Pick P Landenberg Y Shoenfeld J Chapman 2008 Interaction of inflammation, thrombosis, aspirin and enoxaparin in CNS experimental antiphospholipid syndrome Neurobiol Dis 30 56 64 1:CAS:528:DC%2BD1cXjs1Gru74%3D 10.1016/j.nbd.2007.12.004 18308578 (Pubitemid 351381974)
32. J Musiał J Swadźba M Jankowski M Grzywacz S Bazan-Socha A Szczeklik 1997 Thrombin generation measured ex vivo following microvascular injury is increased in SLE patients with antiphospholipid-protein antibodies Thromb Haemost 78 1173 1177 9364980 (Pubitemid 27464581)
33. S Pierangeli EN Harris 2003 Probing antiphospholipid mediated-thrombosis: the interplay between anticardiolipin antibodies and endothelial cells Lupus 12 539 545 1:CAS:528:DC%2BD3sXmsl2qt7Y%3D 10.1191/961203303lu398oa 12892395 (Pubitemid 36890147)
34. W Speiser S Kapiotis CW Kopp I Simonitsch B Jilma B Jansen M Exner A Chott 2001 Effect of intradermal tumor necrosis factor-α-induced inflammation on coagulation factors in dermal vessel endothelium Thromb Haemost 85 362 367 1:CAS:528:DC%2BD3MXhvVKrsLY%3D 11246561 (Pubitemid 32140585)
35. O Amengual T Atsumi MA Khamashta GRV Hughes 1998 The role of the tissue factor pathway in the hypercoagulable state in patients with the antiphospholipid syndrome Thromb Haemost 79 276 281 1:CAS:528:DyaK1cXhtVeju7Y%3D 9493575 (Pubitemid 28065869)
36. Ch Lopez-Pedrera P Buendia MA Aguirre F Velasco MJ Cuadraro 2006 Anthiphospholipid syndrome and tissue factor: a thrombotic couple Lupus 15 161 166 1:CAS:528:DC%2BD28XksVygsr4%3D 10.1191/0961203306lu2276rr 16634370
37. A Hezi-Yamit PW Wong N Bien-Ly LG Komuves KSS Prasad DR Phillips 2005 Synergistic induction of tissue factor by coagulation factor Xa and TNF: evidence for involvement of negative regulatory signaling cascades Proc Natl Acad Sci USA 102 12077 12082 1:CAS:528:DC%2BD2MXps1yru7k%3D 10.1073/pnas. 0504526102 16105945 (Pubitemid 41291131)
38. G Kaplanski P Cacoub C Fernarier V Marin R Gregoire A Gatel JM Durand JR Harle P Bongrand JC Piette 2000 Increased soluble vascular cell adhesion molecule-1 concentrations in patients with primary or systemic lupus erythematosus-related antiphospholipid syndrome: correlations with the severity of thrombosis Arthritis Rheum 43 55 64 1:CAS:528:DC%2BD3cXns1yhtA%3D%3D 10.1002/1529-0131(200001)43:1<55::AID-ANR8>3.0.CO;2-M 10643700 (Pubitemid 30368213)
39. RG Espinola X Liu M Colden-Stanfield J Hall EN Harris SS Pierangeli 2003 E-selectin mediates pathogenic effects of antiphospholipid antibodies J Thromb Haemost 1 843 848 1:CAS:528:DC%2BD2cXktFOiurs%3D 10.1046/j.1538-7836.2003.00119. x 12871424
40. V Combes AC Simon GE Grau D Arnoux L Camoin F Sabatier M Mutin M Sanmarco J Sampol F Dignat-George 1999 In vitro generation of endothelial microparticles and possible prothrombotic activity in patients with lupus anticoagulant J Clin Invest 104 93 102 1:CAS:528:DyaK1MXktlOgsb8%3D 10.1172/JCI4985 10393703 (Pubitemid 29534349)
41. E Raschi C Testoni D Bosisio MO Borghi T Koike A Mantovani PL Meroni 2003 Role of the MyD88 transduction signaling pathway in endothelium activation by antiphospholipid antibodies Blood 101 3495 3500 1:CAS:528:DC%2BD3sXjs1aqsb4%3D 10.1182/blood-2002-08-2349 12531807 (Pubitemid 36857933)
42. M Vega Ostertag K Casper R Swerlick D Ferrara EN Harris SS Pierangeli 2005 Involvement of p38 MAPK in the up-regulation of tissue factor on endothelial cells by antiphospholipid antibodies Arthritis Rheum 52 1545 1554 1:CAS:528:DC%2BD2MXkvFCisrg%3D 10.1002/art.21009 15880836 (Pubitemid 40663946)
43. M Bohgaki T Atsumi Y Yamashita S Yasuda Y Sakai A Furusaki T Bohgaki O Amengual Y Amasaki T Koike 2004 The p38 mitogen-activated protein kinase (MAPK) pathway mediates induction of the tissue factor gene in monocytes stimulated with human monoclonal anti β2GPI antibodies Int Immunol 16 1633 1641 1:CAS:528:DC%2BD2cXos1Wqtbc%3D 10.1093/intimm/dxh166 15466912 (Pubitemid 39480782)
44. 2-glycoprotein 1 antibodies Thromb Haemost 88 851 857 12428105 (Pubitemid 35345346)